Bosh sahifaNWBO • OTCMKTS
add
Northwest Biotherapeutics Inc
Yopilish kursi
0,28 $
Kunlik diapazon
0,28 $ - 0,30 $
Yillik diapazon
0,24 $ - 0,88 $
Bozor kapitalizatsiyasi
366,01 mln USD
Oʻrtacha hajm
2,14 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
OTCMKTS
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 357,00 ming | -12,07% |
Joriy xarajat | 15,16 mln | 115,62% |
Sof foyda | -19,37 mln | -4,27% |
Sof foyda marjasi | -5,43 ming | -18,59% |
Har bir ulushga tushum | — | — |
EBITDA | -14,36 mln | -7,06% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,94 mln | -51,80% |
Jami aktivlari | 29,32 mln | -6,89% |
Jami passivlari | 93,56 mln | 35,70% |
Umumiy kapital | -64,24 mln | — |
Tarqatilgan aksiyalar | 1,26 mlrd | — |
Narxi/balansdagi bahosi | -4,70 | — |
Aktivlardan daromad | -128,60% | — |
Kapitaldan daromad | 916,47% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -19,37 mln | -4,27% |
Operatsiyalardan naqd pul | -8,23 mln | 40,85% |
Sarmoyadan naqd pul | -176,00 ming | 59,73% |
Moliyadan naqd pul | 11,62 mln | -32,14% |
Naqd pulning sof oʻzgarishi | 58,00 ming | -98,76% |
Boʻsh pul | -4,68 mln | 46,45% |
Haqida
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
Tashkil etilgan
1-yan, 1998
Sayt
Xodimlar soni
25
